Genome Research Technology Offers

Yissum - Research Development Company of the Hebrew University posted this:

Mouthwash/Spray that Neutralizes Coronavirus in the Upper Respiratory System Mouthwash/Spray that Neutralizes Coronavirus in the Upper Respiratory System Project ID : 47-2020-10895

Yissum - Research Development Company of the Hebrew University posted this:

Biological Control of Biofilms With Carriers Encapsulating Microbial Predators Amos Nussinovitch & Edouard Jurkevitch – Biological Control of Biofilms by Carriers Encapsulating Microbial Predators– (TTM #10882) – The researchers are developing a biodegradable functional system for delivering biocontrol agents to biofilms. The carriers are made of hydrocolloids which encapsulate a high concentration of Bdellovibrio like organisms (BALOs) which are known to fight biofilms. This system is environmentally friendly, prevents the target biofilm from developing resistance and the release rate of the biocontrol agents can be controlled. Technology Concept Formulated: Seeking Sponsored Research Funding Project ID : 47-2020-10882

Yissum - Research Development Company of the Hebrew University posted this:

Ultra-Low Dose Radiation for Repeat CT Scanning Ultra-Low Dose Radiation for Repeat CT Scanning Project ID : 46-2019-10755

Yissum - Research Development Company of the Hebrew University posted this:

Diagnosis of Parkinson's Disease in Patients with and without Dementia Blood gene transcripts may identify Parkinson's disease patients with and without dementia Project ID : 46-2019-10785

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

RODENT PLATFORM - Luxembourg Centre for Systems Biomedicine The new University rodent facility is a shared resource of the Luxembourg Centre for Systems Biomedicine (LCSB) and the Life Science Research Unit (LSRU) and has been established to assist researchers in the development and analysis of various in vivo models including germ-free animals.

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

Fluorescence Assisted Genome Editing Efficient method to derive genome edited populations by the use of fluorescent markers. The Fluorescence Assisted Genome Editing technique allows deriving correctly edited clones with precision genetic modifications. Produced cells are free from non-edited, random integrations and on-target allele NHEJ-containing populations.

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

BIOMARKER FOR PREDICTION OF RECURRENCE IN COLORECTAL CANCER PATIENTS Approximately 20% of colorectal cancer patients with stage II colorectal cancer experience relapse of the disease. Current clinical-pathologic stratification factors do not allow clear identification of these high-risk patients. The invention is a powerful prognostic biomarker in colorectal cancer, especially in early stages (stages I and II), which might help stratifying patients with stage II for adjuvant chemotherapy. The invention provides a gene expression classifier that distinguishes patients with low or high risk of disease relapse in colorectal cancer and that might be used in the clinics to help clinicians identify high-risk patients and choose the most appropriate treatment for a given patient.

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

Single cell OMICS technologies The Integrative Cell Signalling group at the LCSB investigates changes of cellular heterogeneity in health and disease at single cell resolution. In diverse projects including cell differentiation, cancer heterogeneity and brain chraracterization, we develop and apply single cell RNA sequencing (sc-RNAseq) methods such as Drop-seq, CITE-seq, ATAC-seq, Fluidigm C1, InDrop or SPLiT-seq.

Covid-19 Innovation Challenges by Innoget posted this:

Expertise in molecular biology either experimentally or computationally The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.

IBB-UAB posted this:

Expertise in molecular biology either experimentally or computationally The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.

Pascal Mayer posted this:
CEO at Alphanosos

Alphanosos rapid discovery technology against COVID 19 Alphanosos’ AI guided rapid discovery technology, validated in antimicrobials and anticancer, is expected to develop within 3 weeks of experimental work with a virology partner an anti-COVID-19 treatment composed of a synergistic mix of extracts of edible plants, chosen for being available in large amounts and with good traceability. Such treatment is, therefore, and also thanks to the innovative elaboration process, immediately available to enter large curative clinical trials, to be followed by country-wide deployment in a matter of weeks, for curative and for preventive goals (because of safety which is guaranteed by the edible nature of the mix).

Universitat Politècnica de Catalunya - UPC posted this:

New nanostructured material for tissue regeneration A new ion release system for revascularization and tissue regeneration based of calcium phosphate glass nanoparticles has been patented and developed. Partners to further develop the technology and/or to establish commercial agreements along with technical cooperation are sought.

Yissum - Research Development Company of the Hebrew University posted this:

Diagnosis & Rehabilitation of Language Disorders in Children, Using a Self-Operated Tablet Based App Diagnosis & Rehabilitation of Language Disorders in Children, Using a Self-Operated Tablet Based App Project ID : 19-2019-8746

Yissum - Research Development Company of the Hebrew University posted this:

Enhanced Secretion of Proteins by Tag-Cleaving Cellular System Enhanced Secretion of Proteins by Tag-Cleaving Cellular System Project ID : 6-2019-8747

LUCIA CORAL posted this:
Knowledge Tranfer Manager at National Cancer Institute CRO Aviano

Predictive Kit to identify patients non responding to platinum therapy Predictive Kit to identify patients non responding to platinum therapy. 10 gene signature as a predictive biomarker for platinum treatment against different cancer types. The invention consists in quantifying the expression of 10 genes from tumor cells to detect patients eligible for platinum treatment at higher risk of developing drug resistance and disease progression. Drugs such as cisplatin, oxaliplatin and carboplatin are used to treat various types of worldwide common cancer, but resistance is a frequent event. Patient stratification based on tumor gene expression profile allows to personalize treatment reducing side effects and costs.

Genome Research Technology Offers

Innovation Resources

Sitemaps

Support

Company

Top Posts Categories

Recognitions

Genome Research Technology Offers

Recognitions

Follow us